Helix Biopharma Corp. to Present at RHK Capital Conference in New York
July 24, 2019 17:05 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Submits L-DOS47 IND Application With U.S. FDA for Pancreatic Cancer
July 09, 2019 07:30 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, July 09, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Announces Fiscal Third Quarter 2019 Results
June 11, 2019 07:33 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, June 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates...
Helix BioPharma Corp. Initiates OTCQB Application and Hires U.S. Investor Relations Firm
May 30, 2019 17:48 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes Private Placement
May 29, 2019 18:22 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
L-DOS47 Phase II Randomized Study Advances to Second Cohort
May 01, 2019 08:08 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, May 01, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes Second Tranche of Private Placement
April 29, 2019 18:54 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Closes First Tranche of Private Placement
April 18, 2019 17:05 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 18, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Retains U.S. Legal and Capital Firms to Advise on U.S. Listing
April 17, 2019 17:19 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 17, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Helix BioPharma Corp. Reports Voting Results
April 15, 2019 22:14 ET
|
Helix BioPharma Corp.
RICHMOND HILL, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...